199 related articles for article (PubMed ID: 37198686)
1. Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial.
Cipolla D; Zhang J; Korkmaz B; Chalmers JD; Basso J; Lasala D; Fernandez C; Teper A; Mange KC; Perkins WR; Sullivan EJ
Respir Res; 2023 May; 24(1):133. PubMed ID: 37198686
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis Bronchiectasis.
Chalmers JD; Usansky H; Rubino CM; Teper A; Fernandez C; Zou J; Mange KC
Clin Pharmacokinet; 2022 Oct; 61(10):1457-1469. PubMed ID: 35976570
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetic profile of brensocatib and its effect on pharmacodynamic biomarkers including NE, PR3, and CatG in various rodent species.
Basso J; Chen KJ; Zhou Y; Mark L; LaSala D; Dorfman A; Atalla M; Chun D; Viramontes V; Chang C; Leifer F; McDonald PP; Cipolla DC
Front Pharmacol; 2023; 14():1208780. PubMed ID: 37538173
[TBL] [Abstract][Full Text] [Related]
4. Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.
Chalmers JD; Haworth CS; Metersky ML; Loebinger MR; Blasi F; Sibila O; O'Donnell AE; Sullivan EJ; Mange KC; Fernandez C; Zou J; Daley CL;
N Engl J Med; 2020 Nov; 383(22):2127-2137. PubMed ID: 32897034
[TBL] [Abstract][Full Text] [Related]
5. Periodontal Effects of the Reversible Dipeptidyl Peptidase 1 Inhibitor Brensocatib in Bronchiectasis.
Gunsolley JC; Chalmers JD; Sibila O; Fernandez C; Scannapieco FA
JDR Clin Trans Res; 2023 Sep; ():23800844231196884. PubMed ID: 37746735
[TBL] [Abstract][Full Text] [Related]
6. Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, mitigates interferon-α-accelerated lupus nephritis in mice.
Chen KJ; Zhang J; LaSala D; Basso J; Chun D; Zhou Y; McDonald PP; Perkins WR; Cipolla DC
Front Immunol; 2023; 14():1185727. PubMed ID: 37441081
[TBL] [Abstract][Full Text] [Related]
7. Safety, Tolerability, and Pharmacokinetic Evaluation of Single and Multiple Doses of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib in Healthy Japanese and White Adults.
Usansky H; Yoon E; Teper A; Zou J; Fernandez C
Clin Pharmacol Drug Dev; 2022 Jul; 11(7):832-842. PubMed ID: 35411669
[TBL] [Abstract][Full Text] [Related]
8. Brensocatib (an oral, reversible inhibitor of dipeptidyl peptidase-1) attenuates disease progression in two animal models of rheumatoid arthritis.
McDonald PP; Leifer FG; Basso J; Lasala D; Li D; Chen KJ; Zhang J; Perkins WR; Cipolla DC
Front Immunol; 2023; 14():1231047. PubMed ID: 37638021
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial.
Keir HR; Long MB; Abo-Leyah H; Giam YH; Vadiveloo T; Pembridge T; Hull RC; Delgado L; Band M; McLaren-Neil F; Adamson S; Lahnsteiner E; Gilmour A; Hughes C; New BJ; Connell D; Dowey R; Turton H; Richardson H; Cassidy D; Cooper J; Suntharalingam J; Diwakar L; Russell P; Underwood J; Hicks A; Dosanjh DP; Sage B; Dhasmana D; Spears M; Thompson AR; Brightling C; Smith A; Patel M; George J; Condliffe AM; Shoemark A; MacLennan G; Chalmers JD;
Lancet Respir Med; 2022 Dec; 10(12):1119-1128. PubMed ID: 36075243
[TBL] [Abstract][Full Text] [Related]
10. BI 1291583: a novel selective inhibitor of cathepsin C with superior in vivo profile for the treatment of bronchiectasis.
Kreideweiss S; Schänzle G; Schnapp G; Vintonyak V; Grundl MA
Inflamm Res; 2023 Aug; 72(8):1709-1717. PubMed ID: 37542002
[TBL] [Abstract][Full Text] [Related]
11. N-Arylacyl O-sulfonated aminoglycosides as novel inhibitors of human neutrophil elastase, cathepsin G and proteinase 3.
Craciun I; Fenner AM; Kerns RJ
Glycobiology; 2016 Jul; 26(7):701-709. PubMed ID: 26850997
[TBL] [Abstract][Full Text] [Related]
12. Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples.
Frey DL; Guerra M; Mall MA; Schultz C
J Vis Exp; 2021 May; (171):. PubMed ID: 34096915
[TBL] [Abstract][Full Text] [Related]
13. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
14. Association of admission neutrophil serine proteinases levels with the outcomes of acute ischemic stroke: a prospective cohort study.
Li L; Han Z; Wang R; Fan J; Zheng Y; Huang Y; Yang Z; Yan F; Liu P; Zhao H; Ma Q; Luo Y
J Neuroinflammation; 2023 Mar; 20(1):70. PubMed ID: 36906528
[TBL] [Abstract][Full Text] [Related]
15. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.
Witko-Sarsat V; Halbwachs-Mecarelli L; Schuster A; Nusbaum P; Ueki I; Canteloup S; Lenoir G; Descamps-Latscha B; Nadel JA
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):729-36. PubMed ID: 10101005
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis.
Stockley R; De Soyza A; Gunawardena K; Perrett J; Forsman-Semb K; Entwistle N; Snell N
Respir Med; 2013 Apr; 107(4):524-33. PubMed ID: 23433769
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease.
Chalmers JD; Kettritz R; Korkmaz B
Front Immunol; 2023; 14():1239151. PubMed ID: 38162644
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: A randomized controlled trial.
Watz H; Nagelschmitz J; Kirsten A; Pedersen F; van der Mey D; Schwers S; Bandel TJ; Rabe KF
Pulm Pharmacol Ther; 2019 Jun; 56():86-93. PubMed ID: 30917927
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques.
Oriano M; Terranova L; Sotgiu G; Saderi L; Bellofiore A; Retucci M; Marotta C; Gramegna A; Miglietta D; Carnini C; Marchisio P; Chalmers JD; Aliberti S; Blasi F
Pulm Pharmacol Ther; 2019 Dec; 59():101856. PubMed ID: 31626976
[TBL] [Abstract][Full Text] [Related]
20. Neutrophils and neutrophil serine proteases are increased in the spleens of estrogen-treated C57BL/6 mice and several strains of spontaneous lupus-prone mice.
Dai R; Cowan C; Heid B; Khan D; Liang Z; Pham CT; Ahmed SA
PLoS One; 2017; 12(2):e0172105. PubMed ID: 28192517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
